Curasight AS (XSAT:CURAS) FCF Margin %: 0.00% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:CURAS Curasight AS XSAT:CURAS
24 GF Score
Price kr15.70
! 2 Warning Signs
View Full Analysis

What is Curasight AS FCF Margin %?

Curasight AS XSAT:CURAS -6.27% 24 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates XSAT:CURAS with a GF Score™ of 24/100. The stock has 2 warning signs investors should review. Among 952 Biotechnology companies, Curasight AS ranks worse than 105041.91% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Curasight AS's Free Cash Flow for the three months ended in Mar. 2026 was kr-19.00 Mil. Curasight AS's Revenue for the three months ended in Mar. 2026 was kr0.00 Mil. Therefore, Curasight AS's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Curasight AS's current FCF Yield % is -8.43%.

The historical rank and industry rank for Curasight AS's FCF Margin % or its related term are showing as below:


XSAT:CURAS's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -81.28
* Ranked among companies with meaningful FCF Margin % only.

Curasight AS FCF Margin % Related Terms

Curasight AS FCF Margin % Historical Data

* Premium members only.

The historical data trend for Curasight AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curasight AS FCF Margin % Chart

Curasight AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Curasight AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSAT:CURAS vs VRTX, REGN, RVMD: FCF Margin % Comparison

For the Biotechnology subindustry, Curasight AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curasight AS FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curasight AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Curasight AS's FCF Margin % falls into.


XSAT:CURAS
24GF Score
Curasight AS XSAT:CURAS
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curasight AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Curasight AS's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-51.718/0
= %

Curasight AS's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-19.001/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Curasight AS (XSAT:CURAS) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Curasight AS and its competitors. According to the industry distribution chart, Curasight AS ranks #999999 out of 952 companies in the Biotechnology industry.
Is Curasight AS's FCF Margin % too high?
Curasight AS's current FCF Margin % is 0.00%. Based on the distribution chart, Curasight AS ranks #999999 out of 952 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Curasight AS has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does Curasight AS's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Curasight AS ranks #999999 out of 952 companies for FCF Margin %. This places Curasight AS in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Curasight AS and its competitors. Curasight AS's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curasight AS stock overvalued right now?
Curasight AS (XSAT:CURAS) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Curasight AS's overall GF Score™ is 24/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Curasight AS (XSAT:CURAS), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curasight AS Business Description

Other Exchanges CUS:Germany
Address Ole Maaloes Vej 3, Kobenhavn N, Kobenhavn, DNK, DK-2200
Curasight AS is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors. The Company is focused on advancing its diagnostic and therapeutic platforms through key clinical milestones.
24GF Score

Get the complete analysis for XSAT:CURAS

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr15.70
Price